Featured Research

from universities, journals, and other organizations

New Method For Creating Inducible Stem Cells Is Remarkably Efficient

Date:
September 13, 2008
Source:
Cell Press
Summary:
Some of the most challenging obstacles limiting the reprogramming of mature human cells into stem cells may not seem quite as daunting in the near future. Two independent research papers describe new tools that provide invaluable platforms for elucidating the molecular, genetic, and biochemical mechanisms associated with reprogramming.

Some of the most challenging obstacles limiting the reprogramming of mature human cells into stem cells may not seem quite as daunting in the near future. Two independent research papers, published by Cell Press in the September 11th issue of the journal Cell Stem Cell, describe new tools that provide invaluable platforms for elucidating the molecular, genetic, and biochemical mechanisms associated with reprogramming. The new findings also offer considerable hope toward making the reprogramming process more therapeutically relevant.

Although scientists have successfully reprogrammed mature human skin cells into induced pluripotent stem (iPS) cells by expressing a few key transcription factors, the conversion has been extremely inefficient. "Little is known about the mechanisms by which reprogramming occurs, in part because of the low efficiency," says senior study author Dr. Konrad Hochedlinger from the Harvard Stem Cell Institute. In addition, the iPS cells created thus far have been generated with retroviruses and noninducible lentiviruses, both of which have major limitations that are not compatible with clinical applications.

The Hochedlinger group created a drug-inducible viral system to generate human iPS cells that were molecularly and functionally similar to human embryonic stem cells. This method was unique in that it allowed the researchers to create iPS cells by using the drug doxycycline to control expression of the necessary factors that had been delivered to the cells with viruses.

The researchers then found that when doxycycline was removed and these "primary" iPS cells differentiated to mature cells, another exposure to the drug reactivated the genes required for reprogramming and induced generation of "secondary" iPS cells at a frequency that was far greater that the initial "primary" conversion. The idea of generating these secondary cells was conceived in previous experiments with mice performed in the lab of Dr. Rudolf Jaenisch from the Massachusetts Institute of Technology.

"The secondary system will enable chemical and genetic screening efforts to identify key molecular constituents of reprogramming, as well as important obstacles in this process, and will ultimately lend itself as a powerful tool in the development and optimization methods to produce human iPS cells," explains Dr. Hochedlinger.

In a separate paper, Dr. Jaenisch's group reports on their success in deriving human secondary iPS cells using doxycycline-inducible transgenes. "The drug-inducible system we describe represents a novel, predictable, and highly reproducible platform to study the kinetics of iPS cell generation," says Dr. Jaenisch. "Further, the genetic homogeneity of secondary cells makes chemical and genetic screening approaches to enhance reprogramming efficiency or to replace any of the original reprogramming factors feasible."

Both research teams found that generation of secondary human iPS cells required less time than the initial reprogramming. Interestingly, the time required to generate iPS cells varied among the types of skin cells that were used. For instance, human fibroblasts required several weeks, while keratinocytes required only about 10 days. "The fast kinetics of reprogramming observed for keratinocytes suggests that these cells would be useful for development and optimization of methods to reprogram cells by transient delivery of factors," suggests Dr. Hochedlinger.

The combined results from both research groups represent a major advance toward more efficient strategies for reprogramming differentiated human cells into iPS cells. The methods described here will not only provide critical insight into the reprogramming process, but also, because of the abbreviated time frame, may lead to the generation of cells that will be amenable for therapies, as reprogramming might be achievable without the prohibitive viruses or genetic modifications.

Article 1: The researchers include Nimet Maherali, Harvard Stem Cell Institute, Massachusetts General Hospital Center for Regenerative Medicine, Boston, MA, Massachusetts General Hospital Cancer Center, Boston, MA, Harvard University, Cambridge, MA; Tim Ahfeldt, Harvard Stem Cell Institute, Massachusetts General Hospital Center for Regenerative Medicine, Boston, MA, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Alessandra Rigamonti, Harvard Stem Cell Institute, Massachusetts General Hospital Center for Regenerative Medicine, Boston, MA; Jochen Utikal, Harvard Stem Cell Institute, Massachusetts General Hospital Center for Regenerative Medicine, Boston, MA, Massachusetts General Hospital Cancer Center, Boston, MA; Chad Cowan, Harvard Stem Cell Institute, Massachusetts General Hospital Center for Regenerative Medicine, Boston, MA, Stowers Medical Institute, Boston, MA; and Konrad Hochedlinger, Harvard Stem Cell Institute, Massachusetts General Hospital Center for Regenerative Medicine, Boston, MA, Massachusetts General Hospital Cancer Center, Boston, MA.

Article 2: The researchers include Dirk Hockemeyer, The Whitehead Institute, Cambridge, MA; Frank Soldner, The Whitehead Institute, Cambridge, MA; Elizabeth G. Cook, The Whitehead Institute, Cambridge, MA; Qing Gao, The Whitehead Institute, Cambridge, MA; Maisam Mitalipova, The Whitehead Institute, Cambridge, MA; and Rudolf Jaenisch, The Whitehead Institute, Cambridge, MA, Massachusetts Institute of Technology, Cambridge, MA.


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "New Method For Creating Inducible Stem Cells Is Remarkably Efficient." ScienceDaily. ScienceDaily, 13 September 2008. <www.sciencedaily.com/releases/2008/09/080910133642.htm>.
Cell Press. (2008, September 13). New Method For Creating Inducible Stem Cells Is Remarkably Efficient. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2008/09/080910133642.htm
Cell Press. "New Method For Creating Inducible Stem Cells Is Remarkably Efficient." ScienceDaily. www.sciencedaily.com/releases/2008/09/080910133642.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins